Clinical Trial Update: MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of MT-R followed by autologous stem cell transplantation in patients with newly diagnosed primary central n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• MT-R

Snippet

Sponsor: Jun Zhu | Conditions: Primary Central Nervous System Lymphoma | Phase 2 | Status: UNKNOWN